DDO-5936

CAT: 0804-HY-139301-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-139301-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer[1].
CAS Number
[2355377-13-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ddo-5936.html
Purity
99.20
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CN(S(=O)(C1=C(C)C=C(C)C=C1C)=O)C2=CC=C(NC3=NC(N4CCCC4)=NC=C3)C=C2)O
Molecular Formula
C25H29N5O4S
Molecular Weight
495.59
Precautions
H302, H315, H319, H335
References & Citations
[1]Wang L, et al. Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. J Med Chem. 2020;63 (3) :1281-1297.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-153331-01DDO-2213
HY-149863DDO-8926
HY-144801ADDO-02005
HY-144634-01DDO-7263
HY-132233DDO-2093
HY-155489-01DDO-2728
HY-170668DDO-02267
HY-169947-01DDO-6079
HY-147125DDO-6600
HY-169013DDO-3733

Alternative Products

CatalogName
BA4191-50DDO-5936
CSB-CL006593HUDDO
12-8337-250Anti-Mycobacteria, LAM (MYCO-5936)
588344DDO (DASOX, DDO-1, DDO-2, FLJ45203, aspartic oxidase)
245248DDO (D-Aspartate Oxidase, DASOX, DDO-1, DDO-2, FLJ45203)
034538DDO, ID (DDO, D-aspartate oxidase)
560153-01DDO (FITC)
MBS7048013-01DDO Antibody
T207588-01DDO-6691
T205089-01DDO-3055

Popular Products